Abstract |
New and potent inhibitors of the malarial aspartic proteases plasmepsin (Plm) I and II, from the deadliest malaria parasite Plasmodium falciparum, have been synthesized utilizing Suzuki coupling reactions on previously synthesized bromobenzyloxy-substituted statine-like inhibitors. The enzyme inhibition activity has been improved up to eight times by identifying P1 substituents that effectively bind to the continuous S1-S3 crevice of Plasmepsin I and II. By replacement of the bromo atom in the P1 p-bromobenzyloxy-substituted inhibitors with different aryl substituents, several inhibitors exhibiting K(i) values in the low nanomolar range for both Plm I and II have been identified. Some of these inhibitors are also effective in attenuating parasite growth in red blood cells, with the best inhibitors, compounds 2 and 4, displaying 70% and 83% inhibition, respectively, at a concentration of 5 microM. The design was partially guided by the X-ray crystal structure disclosed herein of the previously synthesized inhibitor 1 in complex with plasmepsin II.
|
Authors | Per-Ola Johansson, Jimmy Lindberg, Michael J Blackman, Ingemar Kvarnström, Lotta Vrang, Elizabeth Hamelink, Anders Hallberg, Asa Rosenquist, Bertil Samuelsson |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 48
Issue 13
Pg. 4400-9
(Jun 30 2005)
ISSN: 0022-2623 [Print] United States |
PMID | 15974592
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antiprotozoal Agents
- Protozoan Proteins
- Aspartic Acid Endopeptidases
- plasmepsin
- plasmepsin II
|
Topics |
- Animals
- Antiprotozoal Agents
(chemical synthesis, chemistry, pharmacology)
- Aspartic Acid Endopeptidases
(antagonists & inhibitors, chemistry)
- Crystallography, X-Ray
- Magnetic Resonance Spectroscopy
- Models, Molecular
- Molecular Conformation
- Plasmodium falciparum
(drug effects, enzymology)
- Protozoan Proteins
- Structure-Activity Relationship
|